Company Encyclopedia
View More
name
Park Ha Biological Tech
BYAH.US
Park Ha Biological Technology Co., Ltd., investment holding company, develops skincare products in the People’s Republic of China. The company operates in two segments, Product Sales and Franchise Service. It offers various products, such as basic skin physical protection, exfoliation, and sebum film repair to surface microecological balance, and anti-aging under the Park Ha brand. It sells products to customers through directly operated retail stores, and franchisees.
129.95 B
BYAH.USMarket value -Rank by Market Cap -/-

Financial Score

19/12/2025 Update
B
Other Specialty RetailIndustry
Industry Ranking12/38
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-729.77%E
    • Profit Margin-701.07%E
    • Gross Margin95.28%A
  • Growth ScoreB
    • Revenue YoY42.65%A
    • Net Profit YoY-4937.72%E
    • Total Assets YoY172.51%A
    • Net Assets YoY297.98%A
  • Cash ScoreB
    • Cash Flow Margin-14.26%D
    • OCF YoY42.65%A
  • Operating ScoreB
    • Turnover0.69B
  • Debt ScoreB
    • Gearing Ratio27.12%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Park Ha Biological Technology Co., Ltd. Announces Nasdaq Ticker Symbol Change to BYAH | PHH Stock News

    Park Ha Biological Technology Co., Ltd. announced a change in its Nasdaq ticker symbol from "PHH" to "BYAH," effective October 28, 2025. This change aims to avoid confusion with a delisted company that previously used the same symbol. CEO Xiaoqiu Zhang stated that the new symbol will enhance the company's brand value. Existing shareholders do not need to take any action regarding this change, and the company's ordinary shares will continue to be listed on Nasdaq with an unchanged CUSIP.

    StockTitan·
    US
    PHH
    0.00%
    US
    BYAH
    +1.42%
    StockTitan·
    US
    PHH
    0.00%
    US
    BYAH
    +1.42%

    Park Ha Biological Technology Co., Ltd. Announces Dual-Class Share Structure

    Park Ha Biological Technology Co., Ltd. (PHH) announced a dual-class share structure following shareholder approval at its Annual General Meeting on October 3, 2025. The company increased its share capital and reclassified existing shares into Class A and Class B shares with different voting rights. Amendments to the memorandum and articles of association were also made, along with a potential share consolidation. These changes aim to enhance governance and market positioning. PHH operates in the biological technology sector, focusing on innovative life science solutions.

    Tip Ranks·
    US
    PHH
    0.00%
    US
    BYAH
    +1.42%
    Tip Ranks·
    US
    PHH
    0.00%
    US
    BYAH
    +1.42%

    INVESTOR ALERT: Morris Kandinov LLP Investigating PHH, WAI, PCLA, and EPWK; Stockholders are Encouraged to Contact the Firm

    Morris Kandinov LLP is investigating potential claims for victims of pump-and-dump schemes involving Park Ha Biological Technology Co. (NASDAQ: PHH), Top KingWin Ltd (NASDAQ: WAI), PicoCELA Inc. (NASDAQ: PCLA), and EPWK Holdings Ltd. (NASDAQ: EPWK). Scammers posed as financial advisors in WhatsApp groups, soliciting victims through fraudulent ads. The firm operates on a contingency fee basis, meaning stockholders incur no fees unless they recover losses. They offer free consultations to discuss legal rights and remedies.

    Benzinga·
    US
    EPWK
    -2.03%
    US
    PHH
    0.00%
    US
    BYAH
    +1.42%
    Benzinga·
    US
    EPWK
    -2.03%
    US
    PHH
    0.00%
    US
    BYAH
    +1.42%

    Can Park Ha Biological Technology Co., Ltd.'s (NASDAQ:PHH) ROE Continue To Surpass The Industry Average?

    Park Ha Biological Technology Co., Ltd. (NASDAQ:PHH) has a Return on Equity (ROE) of 32%, surpassing the industry average of 18% in the Specialty Retail sector. This indicates effective management of shareholder investments, generating $0.32 profit for every dollar invested. Notably, the company has no net debt, enhancing its financial stability and growth potential. While a high ROE is positive, it is essential to consider profit growth rates and market expectations when evaluating investment opportunities.

    Simplywall·
    US
    PHH
    0.00%
    US
    BYAH
    +1.42%
    Simplywall·
    US
    PHH
    0.00%
    US
    BYAH
    +1.42%

    Why Park Ha Biological Technology Co., Ltd. (PHH) is Surging in 2025

    Park Ha Biological Technology Co., Ltd. (NASDAQ:PHH) has seen a significant stock surge of 119.08% year-to-date in 2025, primarily driven by its successful IPO on December 27, 2024, which raised $4.8 million. The company specializes in private-label skincare products and operates franchise beauty stores in China. The rise in stock price is attributed to post-IPO momentum and increased interest from retail and overseas investors. Despite this growth, the article suggests that AI stocks may offer greater investment potential.

    insidermonkey·
    US
    PHH
    0.00%
    US
    BYAH
    +1.42%
    insidermonkey·
    US
    PHH
    0.00%
    US
    BYAH
    +1.42%
    © 2025 Longbridge｜Disclaimer